Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ProKidney Corp. - Class A Ordinary Shares
(NQ:
PROK
)
1.720
+0.010 (+0.58%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ProKidney Corp. - Class A Ordinary Shares
< Previous
1
2
3
4
5
6
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
June 11, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers worth checking out on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 10, 2024
Via
Benzinga
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
June 10, 2024
From
ProKidney
Via
GlobeNewswire
PROK Stock Earnings: ProKidney Beats EPS for Q1 2024
↗
May 10, 2024
PROK stock results show that ProKidney beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Is Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock?
↗
October 16, 2023
PROK stock is in focus following a slew of sales from SPAC sponsor Chamath Palihapitiya. Here's what you need to know.
Via
InvestorPlace
Why Shares of ProKidney Were Dropping Thursday
↗
October 12, 2023
Two factors led to the stock's slide on Thursday.
Via
The Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 10, 2024
Pre-market stock movers are worth diving into on Monday and we have all of the latest news worth knowing about this morning!
Via
InvestorPlace
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
June 10, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
May 21, 2024
From
ProKidney
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 14, 2024
Via
Benzinga
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
May 10, 2024
From
ProKidney
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 15, 2024
Via
Benzinga
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
March 25, 2024
From
ProKidney
Via
GlobeNewswire
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 15, 2024
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 08, 2024
Via
Benzinga
ProKidney to Participate in Jefferies Biotech on the Bay Summit
February 29, 2024
From
ProKidney
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 16, 2024
Via
Benzinga
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
November 30, 2023
Former CEO of Africa Healthcare Network brings extensive understanding of kidney disease to ProKidney
From
ProKidney
Via
GlobeNewswire
7 Penny Stocks With Low Floats and High Short Interest
↗
November 24, 2023
Is the 'smart money' on the money shorting these low-float penny stocks, or is there the opportunity for a short squeeze? Let's find out.
Via
InvestorPlace
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
November 21, 2023
From
ProKidney
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 20, 2023
Via
Benzinga
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
November 16, 2023
Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.
Via
Benzinga
ProKidney Reports Third Quarter Financial Results
November 14, 2023
From
ProKidney
Via
GlobeNewswire
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
November 13, 2023
From
ProKidney
Via
GlobeNewswire
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
October 30, 2023
Total of 6 abstracts accepted for publication in Kidney Week 2023 program
From
ProKidney
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 27, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
